Cogstate
Cogstate Ltd is a neuroscience company focused on optimizing brain health assessments. They provide digital cognitive assessment tools and services for clinical trials, healthcare, and research, aiming to improve the detection and measurement of cognitive function. Their solutions support the development of new medicines and enable earlier clinical insights in healthcare.
Short position
Cogstate (ASX:CGS) has 0.03% of its shares on issue reported as short positions as of 5 Oct 2026, or about 46,761 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.81% in July 2023. CGS is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Cogstate (CGS) company profile
Profile, insiders and operations
Company
AI-generated research profile of Cogstate
CGS intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links